Led Qureight's $20M Series B to expand its AI-powered imaging platform for clinical trials.
Qureight is a tech-first, AI-powered imaging CRO that delivers enterprise-grade imaging and precision endpoints for clinical trials, particularly in lung and heart diseases
Qureight is a tech-first, AI-powered imaging CRO that delivers enterprise-grade imaging and precision endpoints for clinical trials, particularly in lung and heart diseases.